Cargando…
Ferroptosis‐Enhanced Immunotherapy with an Injectable Dextran‐Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma
Malignant ascites in advanced hepatocellular carcinoma (HCC) is a complex clinical problem that lacks effective treatments. Due to the insensitivity of advanced HCC cells to traditional chemotherapies, low drug accumulation, and limited drug residence time in the peritoneal cavity, the therapeutic e...
Autores principales: | Meng, Jingshu, Yang, Xiao, Huang, Jing, Tuo, Zhan, Hu, Yan, Liao, Zhiyun, Tian, Yu, Deng, Suke, Deng, Yue, Zhou, Zhiyuan, Lovell, Jonathan F., Jin, Honglin, Liu, Yang, Yang, Kunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369279/ https://www.ncbi.nlm.nih.gov/pubmed/37132587 http://dx.doi.org/10.1002/advs.202300517 |
Ejemplares similares
-
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel
por: Dai, Xiaomeng, et al.
Publicado: (2020) -
USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer
por: Dai, Xiaomeng, et al.
Publicado: (2020) -
Radiated tumor cell-derived microparticles effectively kill stem-like tumor cells by increasing reactive oxygen species
por: Hu, Yan, et al.
Publicado: (2023) -
Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022) -
Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy
por: Chan, Maggie, et al.
Publicado: (2015)